Table 1. Classification of adRP and adCSNB mutations.
Classification of rhodopsin mutations described in HGMD (http://www.hgmd.cf.ac.uk/) based on their experimentally studied biochemical and cellular characteristics. Italicised substitutions are observed in the gnomAD dataset at a frequency of ~ 1:80,000 or more and might be non-pathogenic substitutions. § might behave as class 4 after 11-cis-retinal rescue. † might behave as class 2 on overexpression, but class 4 in vivo.
| Classification | Key features | Mutations |
|---|---|---|
| 1 | Post Golgi trafficking and OS targeting | L328P, T342M, Q344R/P/ter, V345L/M, A346P, P347A/R/Q/L/S/T, ter349/Q/E |
| 2 | Misfolding, ER retention and instability | N15S§, T17M†, V20G§, P23A/H/L§, Q28H§, G51R/V, P53R, T58R/M, V87D, G89D, G106R/W, C110F/R/S/Y, E113K, L125R, W161R, A164E/V, C167R/W, P171Q/L/S, Y178N/D/C, E181K, G182S/V, C185R, C187G/Y, G188R/E, D190N/G/Y, H211R/P, C222R, P267R/L, S270R, K296N/E/M |
| 3 | Disrupted vesicular traffic and endocytosis | R135G/L/P/W |
| 4 | Altered post-translational modifications and reduced stability | T4K†, T17M†, M39R, N55K, G90V |
| 5 | Altered transducin activation | M44T, V137M |
| 6 | Constitutive activation | G90D, T94I, A292E, A295V |
| 7 | Dimerization deficiency | F45L, V209M, F220C |
| Unclassified | No observed biochemical or cellular defect or not studied in detail | P12R, R21C, Q28H, L40R, L46R, L47R, F52Y, F56Y, L57R, Y60ter, Q64ter, R69H, N78I, L79P, V87L, L88P, T92I, T97I, V104F, G109R, G114D/V, E122G, W126L/ter, S127F, L131P, Y136ter, C140S, T160T, M163T, A169P, P170H/R, S176F, P180A/S, Q184P, S186P/W, Y191C, T193M, M207R/K, V210F, I214N, P215L/T, M216R/L/K, R252P, T289P, S297R, A298D, K311E, N315ter, E341K, S343C |